| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |